2023 ICD-10-CM Diagnosis Code E85.89

Other amyloidosis

    2018 - New Code 2019 2020 2021 2022 2023 Billable/Specific Code
  • E85.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM E85.89 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of E85.89 - other international versions of ICD-10 E85.89 may differ.
The following code(s) above E85.89 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to E85.89:
  • E00-E89
    2023 ICD-10-CM Range E00-E89

    Endocrine, nutritional and metabolic diseases

    Note
    • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
    Type 1 Excludes
    • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
    Endocrine, nutritional and metabolic diseases
  • E70-E88
    2023 ICD-10-CM Range E70-E88

    Metabolic disorders

    Type 1 Excludes
    • androgen insensitivity syndrome (E34.5-)
    • congenital adrenal hyperplasia (E25.0)
    • hemolytic anemias attributable to enzyme disorders (D55.-)
    • Marfan's syndrome (Q87.4)
    • 5-alpha-reductase deficiency (E29.1)
    Type 2 Excludes
    • Ehlers-Danlos syndromes (Q79.6-)
    Metabolic disorders
  • E85
    ICD-10-CM Diagnosis Code E85

    Amyloidosis

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Type 2 Excludes
    Amyloidosis
ICD-10-CM E85.89 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 545 Connective tissue disorders with mcc
  • 546 Connective tissue disorders with cc
  • 547 Connective tissue disorders without cc/mcc

Convert E85.89 to ICD-9-CM

Code History
  • 2018 (effective 10/1/2017): New code
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to E85.89:
  • Amyloidosis (generalized) (primary) E85.9
    ICD-10-CM Diagnosis Code E85.9

    Amyloidosis, unspecified

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    • specified NEC E85.89
  • Degeneration, degenerative
    • capillaries (fatty) I78.8
      ICD-10-CM Diagnosis Code I78.8

      Other diseases of capillaries

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
      • amyloid E85.89
  • Paramyloidosis E85.89

ICD-10-CM Codes Adjacent To E85.89
E84.9 Cystic fibrosis, unspecified
E85 Amyloidosis
E85.0 Non-neuropathic heredofamilial amyloidosis
E85.1 Neuropathic heredofamilial amyloidosis
E85.2 Heredofamilial amyloidosis, unspecified
E85.3 Secondary systemic amyloidosis
E85.4 Organ-limited amyloidosis
E85.8 Other amyloidosis
E85.81 Light chain (AL) amyloidosis
E85.82 Wild-type transthyretin-related (ATTR) amyloidosis
E85.89 Other amyloidosis
E85.9 Amyloidosis, unspecified
E86 Volume depletion
E86.0 Dehydration
E86.1 Hypovolemia
E86.9 Volume depletion, unspecified
E87 Other disorders of fluid, electrolyte and acid-base balance
E87.0 Hyperosmolality and hypernatremia
E87.1 Hypo-osmolality and hyponatremia
E87.2 Acidosis
E87.20 …… unspecified

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.